AVRO insider filings
AVROBIO, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-05-15. Screen AVRO transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for AVRO between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — AVROBIO, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-05-15 | 4 | Leonard Braden Michael — 10% owner | Purchase (P): 253,700 @ $1.24 · Purchase (P): 216,053 @ $1.26 · Purchase (P): 296,882 @ $1.30 | EDGAR |
| 2024-02-05 | 4 | Golipour Azadeh — Chief Technology Officer | Option exercise (M): 37,334 @ $0 · Tax withholding (F): 12,232 @ $1.20 · Option exercise (M): 37,334 (derivative) @ $0 | EDGAR |
| 2024-02-05 | 4 | Ridha Essra — Chief Medical Officer | Option exercise (M): 32,834 @ $0 · Tax withholding (F): 16,953 @ $1.20 · Option exercise (M): 32,834 (derivative) @ $0 | EDGAR |
| 2024-02-05 | 4 | Ostrowski Erik — Interim CEO, President and CFO | Option exercise (M): 40,084 @ $0 · Tax withholding (F): 13,099 @ $1.20 · Option exercise (M): 40,084 (derivative) @ $0 | EDGAR |
| 2024-02-05 | 4 | Avruch Steven — Chief Legal Officer | Option exercise (M): 32,834 @ $0 · Tax withholding (F): 10,812 @ $1.20 · Option exercise (M): 32,834 (derivative) @ $0 | EDGAR |
| 2023-07-03 | 4 | Ostrowski Erik — Interim CEO, President and CFO | Grant/award (A): 70,000 (derivative) @ $0 | EDGAR |
| 2023-06-13 | 4 | Golipour Azadeh — Chief Technology Officer | Tax withholding (F): 5,463 @ $1.19 · Tax withholding (F): 111 @ $1.21 | EDGAR |
| 2023-06-08 | 4 | PAIGE CHRISTOPHER — Director | Grant/award (A): 17,643 (derivative) @ $0 | EDGAR |
| 2023-06-08 | 4 | Jenkins Annalisa — Director | Grant/award (A): 17,643 (derivative) @ $0 | EDGAR |
| 2023-06-08 | 4 | Vickers Philip J. — Director | Grant/award (A): 17,643 (derivative) @ $0 | EDGAR |
| 2023-06-08 | 4 | Farfel Gail M — Director | Grant/award (A): 17,643 (derivative) @ $0 | EDGAR |
| 2023-06-08 | 4 | Booth Bruce — Director | Grant/award (A): 17,643 (derivative) @ $0 | EDGAR |
| 2023-06-08 | 4 | CLARK IAN T — Director | Grant/award (A): 17,643 (derivative) @ $0 | EDGAR |
| 2023-06-08 | 4 | Donenberg Phillip B. — Director | Grant/award (A): 17,643 (derivative) @ $0 | EDGAR |
| 2023-02-10 | 4 | Ridha Essra — Chief Medical Officer | Grant/award (A): 131,333 (derivative) @ $0 | EDGAR |
| 2023-02-10 | 4 | Ostrowski Erik — Chief Financial Officer | Grant/award (A): 160,333 (derivative) @ $0 | EDGAR |
| 2023-02-10 | 4 | Golipour Azadeh — Chief Technology Officer | Grant/award (A): 149,333 (derivative) @ $0 | EDGAR |
| 2023-02-10 | 4 | MACKAY GEOFFREY — President & CEO, Director | Grant/award (A): 300,667 (derivative) @ $0 | EDGAR |
| 2023-02-10 | 4 | Avruch Steven — Chief Legal Officer | Grant/award (A): 131,333 (derivative) @ $0 | EDGAR |
| 2023-02-10 | 4 | Petersen Deanna M — Chief Business Officer | Grant/award (A): 86,667 (derivative) @ $0 | EDGAR |
| 2023-01-26 | 4 | MACKAY GEOFFREY — President & CEO, Director | Gift (G): 245,123 @ $0 · Gift (G): 245,123 @ $0 · Option exercise (M): 45,999 @ $0.91 · Option exercise (M): 45,999 (derivative) @ $0 | EDGAR |
| 2022-12-28 | 4 | MACKAY GEOFFREY — President & CEO, Director | Option exercise (M): 142,013 @ $0.41 · Option exercise (M): 142,013 (derivative) @ $0 | EDGAR |
| 2022-12-09 | 4 | Ridha Essra — Chief Medical Officer | Grant/award (A): 183,000 (derivative) @ $0 | EDGAR |
| 2022-12-09 | 4 | MACKAY GEOFFREY — President & CEO, Director | Grant/award (A): 388,000 (derivative) @ $0 | EDGAR |
| 2022-12-09 | 4 | Ostrowski Erik — Chief Financial Officer | Grant/award (A): 221,000 (derivative) @ $0 | EDGAR |
| 2022-12-09 | 4 | Golipour Azadeh — Chief Technology Officer | Grant/award (A): 165,000 (derivative) @ $0 | EDGAR |
| 2022-12-09 | 4 | Avruch Steven — Chief Legal Officer | Grant/award (A): 169,500 (derivative) @ $0 | EDGAR |
| 2022-12-09 | 4 | Petersen Deanna M — Chief Business Officer | Grant/award (A): 111,500 (derivative) @ $0 | EDGAR |
| 2022-06-10 | 4 | PAIGE CHRISTOPHER — Director | Grant/award (A): 17,478 (derivative) @ $0 · Grant/award (A): 17,478 (derivative) @ $0 | EDGAR |
| 2022-06-10 | 4 | Jenkins Annalisa — Director | Grant/award (A): 17,478 (derivative) @ $0 · Grant/award (A): 17,478 (derivative) @ $0 | EDGAR |
| 2022-06-10 | 4 | Vickers Philip J. — Director | Grant/award (A): 17,478 (derivative) @ $0 · Grant/award (A): 17,478 (derivative) @ $0 | EDGAR |
| 2022-06-10 | 4 | Farfel Gail M — Director | Grant/award (A): 17,478 (derivative) @ $0 · Grant/award (A): 17,478 (derivative) @ $0 | EDGAR |
| 2022-06-10 | 4 | Booth Bruce — Director | Grant/award (A): 17,478 (derivative) @ $0 · Grant/award (A): 17,478 (derivative) @ $0 | EDGAR |
| 2022-06-10 | 4 | CLARK IAN T — Director | Grant/award (A): 17,478 (derivative) @ $0 · Grant/award (A): 17,478 (derivative) @ $0 | EDGAR |
| 2022-06-10 | 4 | Donenberg Phillip B. — Director | Grant/award (A): 17,478 (derivative) @ $0 · Grant/award (A): 17,478 (derivative) @ $0 | EDGAR |
| 2022-02-04 | 4 | MACKAY GEOFFREY — President & CEO, Director | Grant/award (A): 405,000 (derivative) @ $0 · Grant/award (A): 328,500 (derivative) @ $0 | EDGAR |
| 2022-02-04 | 4 | Ridha Essra — Chief Medical Officer | Grant/award (A): 75,000 (derivative) @ $0 · Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2022-02-04 | 4 | Avruch Steven — Chief Legal Officer | Grant/award (A): 105,000 (derivative) @ $0 · Grant/award (A): 90,000 (derivative) @ $0 | EDGAR |
| 2022-02-04 | 4 | Ostrowski Erik — Chief Financial Officer | Grant/award (A): 170,000 (derivative) @ $0 · Grant/award (A): 145,000 (derivative) @ $0 | EDGAR |
| 2022-02-04 | 4 | Petersen Deanna M — Chief Business Officer | Grant/award (A): 100,000 (derivative) @ $0 · Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2021-11-02 | 4 | Ridha Essra — Chief Medical Officer | Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
| 2021-07-08 | 4 | Vickers Philip J. — Director | Purchase (P): 4,800 @ $8.35 | EDGAR |
| 2021-06-14 | 4 | PAIGE CHRISTOPHER — Director | Grant/award (A): 17,438 (derivative) @ $0 | EDGAR |
| 2021-06-14 | 4 | Jenkins Annalisa — Director | Grant/award (A): 17,438 (derivative) @ $0 | EDGAR |
| 2021-06-14 | 4 | Vickers Philip J. — Director | Grant/award (A): 17,438 (derivative) @ $0 | EDGAR |
| 2021-06-14 | 4 | Farfel Gail M — Director | Grant/award (A): 17,438 (derivative) @ $0 | EDGAR |
| 2021-06-14 | 4 | Petersen Deanna M — Chief Business Officer | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2021-06-14 | 4 | Booth Bruce — Director | Grant/award (A): 17,438 (derivative) @ $0 | EDGAR |
| 2021-06-14 | 4 | CLARK IAN T — Director | Grant/award (A): 17,438 (derivative) @ $0 | EDGAR |
| 2021-06-14 | 4 | Donenberg Phillip B. — Director | Grant/award (A): 17,438 (derivative) @ $0 | EDGAR |
Recent 8-K events — AVROBIO, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-05 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-29 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-10 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-23 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-26 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-24 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-30 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=AVRO returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs